Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

The risk of amyotrophic lateral sclerosis after cancer in U.S. elderly adults: a population-based prospective study.

Freedman DM, Wu J, Daugherty SE, Kuncl RW, Enewold LR, Pfeiffer RM.

Int J Cancer. 2014 Oct 1;135(7):1745-50. doi: 10.1002/ijc.28795. Epub 2014 Feb 28.

2.

Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.

Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, Muravov O, Horton K; Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia; Centers for Disease Control and Prevention (CDC).

MMWR Suppl. 2014 Jul 25;63(7):1-14.

PMID:
25054277
3.

The association between cancer and amyotrophic lateral sclerosis.

Freedman DM, Curtis RE, Daugherty SE, Goedert JJ, Kuncl RW, Tucker MA.

Cancer Causes Control. 2013 Jan;24(1):55-60. doi: 10.1007/s10552-012-0089-5. Epub 2012 Oct 23.

4.

Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.

Mehta P, Kaye W, Bryan L, Larson T, Copeland T, Wu J, Muravov O, Horton K.

MMWR Surveill Summ. 2016 Aug 5;65(8):1-12. doi: 10.15585/mmwr.ss6508a1.

PMID:
27490513
6.

Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly.

Engels EA, Pfeiffer RM, Ricker W, Wheeler W, Parsons R, Warren JL.

Am J Epidemiol. 2011 Oct 1;174(7):860-70. doi: 10.1093/aje/kwr146. Epub 2011 Aug 4.

7.

No association between biopsy-verified celiac disease and subsequent amyotrophic lateral sclerosis--a population-based cohort study.

Ludvigsson JF, Mariosa D, Lebwohl B, Fang F.

Eur J Neurol. 2014 Jul;21(7):976-82. doi: 10.1111/ene.12419. Epub 2014 Apr 7.

8.

Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort.

Weisskopf MG, Cudkowicz ME, Johnson N.

Epidemiology. 2015 Nov;26(6):831-8. doi: 10.1097/EDE.0000000000000376.

9.

Epidemiology of amyotrophic lateral sclerosis.

Kurtzke JF.

Adv Neurol. 1982;36:281-302.

PMID:
6983824
10.

Long-term survival in amyotrophic lateral sclerosis: a population-based study.

Pupillo E, Messina P, Logroscino G, Beghi E; SLALOM Group.

Ann Neurol. 2014 Feb;75(2):287-97. doi: 10.1002/ana.24096. Epub 2014 Feb 24.

PMID:
24382602
11.

Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort.

Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, Linseisen J, Kaaks R, Allen NE, Roddam AW, Boshuizen HC, Peeters PH, Palli D, Mattiello A, Sieri S, Tumino R, Jiménez-Martín JM, Díaz MJ, Suarez LR, Trichopoulou A, Agudo A, Arriola L, Barricante-Gurrea A, Bingham S, Khaw KT, Manjer J, Lindkvist B, Overvad K, Bach FW, Tjønneland A, Olsen A, Bergmann MM, Boeing H, Clavel-Chapelon F, Lund E, Hallmans G, Middleton L, Vineis P, Riboli E.

Ann Neurol. 2009 Apr;65(4):378-85. doi: 10.1002/ana.21653.

PMID:
19399866
12.

The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation.

Lo Coco D, Marchese S, La Bella V, Piccoli T, Lo Coco A.

Chest. 2007 Jul;132(1):64-9. Epub 2007 May 2.

PMID:
17475635
13.

Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study.

Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, Lepore V, Simone IL, Lamberti P, Serlenga L, Logroscino G; SLAP Registry.

J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):33-7. Epub 2007 Jun 5.

PMID:
17550991
14.

Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study.

Gallo V, Vanacore N, Bueno-de-Mesquita HB, Vermeulen R, Brayne C, Pearce N, Wark PA, Ward HA, Ferrari P, Jenab M, Andersen PM, Wennberg P, Wareham N, Katzke V, Kaaks R, Weiderpass E, Peeters PH, Mattiello A, Pala V, Barricante A, Chirlaque MD, Travier N, Travis RC, Sanchez MJ, Pessah-Rasmussen H, Petersson J, Tjønneland A, Tumino R, Quiros JR, Trichopoulou A, Kyrozis A, Oikonomidou D, Masala G, Sacerdote C, Arriola L, Boeing H, Vigl M, Claver-Chapelon F, Middleton L, Riboli E, Vineis P.

Eur J Epidemiol. 2016 Mar;31(3):255-66. doi: 10.1007/s10654-016-0119-9. Epub 2016 Mar 11.

15.

Population-based risks for cancer in patients with ALS.

Gibson SB, Abbott D, Farnham JM, Thai KK, McLean H, Figueroa KP, Bromberg MB, Pulst SM, Cannon-Albright L.

Neurology. 2016 Jul 19;87(3):289-94. doi: 10.1212/WNL.0000000000002757. Epub 2016 May 11.

16.

Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts.

Wang H, O'Reilly ÉJ, Weisskopf MG, Logroscino G, McCullough ML, Thun MJ, Schatzkin A, Kolonel LN, Ascherio A.

Arch Neurol. 2011 Feb;68(2):207-13. doi: 10.1001/archneurol.2010.367.

17.

Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study.

de Jong SW, Huisman MH, Sutedja NA, van der Kooi AJ, de Visser M, Schelhaas HJ, Fischer K, Veldink JH, van den Berg LH.

Am J Epidemiol. 2012 Aug 1;176(3):233-9. doi: 10.1093/aje/kws015. Epub 2012 Jul 11.

PMID:
22791740
18.

Survival of patients with amyotrophic lateral sclerosis in a population-based registry.

Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A.

Neuroepidemiology. 2005;25(3):114-9. Epub 2005 Jun 13.

PMID:
15956808
19.

Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database.

Williams JR, Fitzhenry D, Grant L, Martyn D, Kerr DA.

BMC Neurol. 2013 Nov 4;13:160. doi: 10.1186/1471-2377-13-160.

20.

Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.

Mukherjee D, Chaichana KL, Gokaslan ZL, Aaronson O, Cheng JS, McGirt MJ.

J Neurosurg Spine. 2011 Feb;14(2):143-50. doi: 10.3171/2010.10.SPINE10189. Epub 2010 Dec 24.

PMID:
21184634

Supplemental Content

Support Center